Researcher profile

Makoto Sasaki

Makoto Sasaki contributes to research discovery and scholarly infrastructure.

ResearcherAffiliation not importedOpen to collaborate

Trust snapshot

Quick read

Trust 13 - UnverifiedVerification L1Unclaimed author
2works
0followers
5topics
4close collaborators

Actions

Decide how to stay connected

Follow researcher0

Identity and collaboration

How to connect with this researcher

Claiming links this public author record to a researcher profile and unlocks direct collaboration workflows.

Log in to claim

Direct collaboration

Open a focused conversation when the fit is right

Claim this author entity first to unlock direct invitations.

Research graph

See the researcher in context

Open full explorer

Inspect adjacent work, topics, institutions and collaborators without jumping out to a separate graph page.

Building this graph slice

BZPEER is loading the nearby papers, people, topics and institutions for this page.

Published work

2 published item(s)

preprint2022arXiv

Exploring the MeV Sky with a Combined Coded Mask and Compton Telescope: The Galactic Explorer with a Coded Aperture Mask Compton Telescope (GECCO)

The sky at MeV energies is currently poorly explored. Here we present an innovative mission concept that builds on and improves past and currently proposed missions at such energies. We outline the motivations for combining a coded mask and a Compton telescope and we define the scientific goals of such a mission. The Galactic Explorer with a Coded Aperture Mask Compton Telescope (GECCO) is a novel concept for a next-generation telescope covering hard X-ray and soft gamma-ray energies. The potential and importance of this approach that bridges the observational gap in the MeV energy range are presented. With the unprecedented angular resolution of the coded mask telescope combined with the sensitive Compton telescope, a mission such as GECCO can disentangle the discrete sources from the truly diffuse emission. Individual Galactic and extragalactic sources are detected. This also allows to understand the gamma-ray Galactic center excess and the Fermi Bubbles, and to trace the low-energy cosmic rays, and their propagation in the Galaxy. Nuclear and annihilation lines are spatially and spectrally resolved from the continuum emission and from sources, addressing the role of low-energy cosmic rays in star formation and galaxy evolution, the origin of the 511 keV positron line, fundamental physics, and the chemical enrichment in the Galaxy. Such an instrument also detects explosive transient gamma-ray sources, which enable identifying and studying the astrophysical objects that produce gravitational waves and neutrinos in a multi-messenger context. By looking at a poorly explored energy band it also allows discoveries of new astrophysical phenomena.

preprint2022arXiv

Theoretical Analysis of SIRVVD Model to Provide Insight on the Target Rate of COVID-19/SARS-CoV-2 Vaccination in Japan

The effectiveness of the first and second dose vaccinations are different for COVID-19; therefore, a susceptible-infected-recovered-vaccination1-vaccination2-death (SIRVVD) model that can represent the states of the first and second vaccination doses has been proposed. By the previous study, we can carry out simulating the spread of infectious disease considering the effects of the first and second doses of the vaccination based on the SIRVVD model. However, theoretical analysis of the SIRVVD Model is insufficient. Therefore, we obtained an analytical expression of the infectious number, by treating the numbers of susceptible persons and vaccinated persons as parameters. We used the solution to determine the target rate of the vaccination for decreasing the infection numbers of the COVID-19 Delta variant (B.1.617) in Japan. Further, we investigated the target vaccination rates for cases with strong or weak variants by comparison with the COVID-19 Delta variant (B.1.617). This study contributes to the mathematical development of the SIRVVD model and provides insight into the target rate of the vaccination to decrease the number of infections.